Brief: Aethlon Medical Announces Issuance Of Hemopurifier® Patents For The Treatment Of Long Covid And Covid-19-Associated Coagulopathy (Cac)
03/09/2025 15:52
Sept 3 (Reuters) - Aethlon Medical Inc AEMD.O: AETHLON MEDICAL ANNOUNCES ISSUANCE OF HEMOPURIFIER® PATENTS FOR THE TREATMENT OF LONG COVID AND COVID-19-ASSOCIATED COAGULOPATHY (CAC) Source text: ID:nPnc5Gtgya Further company coverage: AEMD.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aethlon Medical
See all newsU.S. STOCKS ON THE MOVE -Nebius, Securitize, Viant Technology
U.S. STOCKS ON THE MOVE -GlobalFoundries, Lucid, Phillips 66
U.S. STOCKS ON THE MOVE-Generac, Jefferies, Applied Digital
U.S. STOCKS ON THE MOVE-Generac, Jefferies, Aethlon Medical
Aethlon Medical skyrockets after merger with North Immunology